Comparative Gene Expression Profiling in Human Induced Pluripotent Stem Cell Derived Cardiocytes and Human and Cynomolgus Heart Tissue

*Compound Safety Prediction, Pfizer, Inc., Groton, Connecticut 06340; †Immunology and Autoimmunity, Pfizer, Inc., Cambridge, Massachusetts 02140; ‡Global Safety Pharmacology, Pfizer, Inc., Groton, Connecticut 06340; §Non-clinical Statistics, Pfizer, Inc., Groton, Connecticut 06340; ¶Worldwide Comparative Medicine, Pfizer, Inc., Groton, Connecticut 06340; ||Cellular Dynamics International, Madison, Wisconsin 53711; |||Orphan and Genetic Diseases, Pfizer, Inc., Cambridge, Massachusetts 02140; and ||||Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Groton, Connecticut 06340